Morocco’s Genome Project study represents the first complete mapping of the human genome conducted in Morocco, and one of the ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

Through the Miraa Farmers and Pluckers Association Chairman, Japhet Mutuma, the farmers revealed that traders and exporters ...

Nurse practitioners should listen to patients’ concerns and be ready with questions when it comes to germline testing, according to an expert.

US-based Alzheon’s Alzheimer’s disease pill has failed in a Phase III trial, but the biopharma still holds hope for the drug after seeing signals in a subgroup of patients. The company said that while ...

Colossal Biosciences’ Romulus, Remus, and Khaleesi might have broken the internet, but a lot of that is becoming what qualifies as a “dire wolf,” anyway?

A new study published in Life Science Alliance reveals a key genetic connection between cancer susceptibility and tissue ...

The woman’s brain was donated to research after her death, and it was analyzed by researchers for signs of Alzheimer’s ...

Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...